Jun Qi

Affiliations: 
Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States 
Google:
"Jun Qi"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Souroullas GP, Jeck WR, Parker JS, et al. (2024) Author Correction: An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation. Nature Medicine
Duplaquet L, So K, Ying AW, et al. (2024) Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer. Biorxiv : the Preprint Server For Biology
L Vu KA, Kumari K, Liu BH, et al. (2023) SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis. Biorxiv : the Preprint Server For Biology
Li M, Yang L, Chan AKN, et al. (2023) Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206584
Feng Y, Cai L, Pook M, et al. (2023) BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Biorxiv : the Preprint Server For Biology
Sevinç K, Sevinç GG, Cavga AD, et al. (2022) BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. Stem Cell Reports
Guan X, Cheryala N, Karim RM, et al. (2022) Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity. Journal of Medicinal Chemistry
Ding J, Cui XG, Chen HJ, et al. (2022) Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma. Cancers. 14
Zullow HJ, Sankar A, Ingram DR, et al. (2022) The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Molecular Cell
Wang MY, Liow P, Guzman MIT, et al. (2022) Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. Acs Chemical Biology. 17: 744-755
See more...